Company Filing History:
Years Active: 1997-2008
Title: David H Parma: Innovator in Nucleic Acid Ligands
Introduction
David H Parma is a prominent inventor based in Boulder, CO (US). He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid ligands. With a total of 10 patents to his name, his work has advanced the understanding and application of molecular interactions.
Latest Patents
Among his latest patents, one notable invention is the development of high-affinity nucleic acid ligands to lectins. This invention discloses high-affinity oligonucleotide ligands that can bind to various lectins, including wheat germ agglutinin, L-selectin, E-selectin, and P-selectin. The methods for obtaining such ligands are also detailed in this patent. Another significant patent involves Tenascin-C nucleic acid ligands, where methods for identifying and preparing these ligands are described. This includes specific RNA ligands to tenascin-C identified by the SELEX method, along with methods for detecting disease conditions in biological tissues expressing tenascin-C.
Career Highlights
David H Parma has worked with notable companies in the biotechnology sector, including Gilead Sciences, Inc. and Nexstar Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in the field and the successful development of his patented technologies.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues such as Larry M Gold and Brian James Hicke. These collaborations have further enriched his research and innovation efforts.
Conclusion
David H Parma's contributions to the field of nucleic acid ligands have had a profound impact on biotechnology. His innovative patents and collaborations highlight his role as a leading inventor in this specialized area.